27 sierpnia 2018
Annual Immuno-Oncology Summit, 27-31 August 2018, Boston, MA, USA
Rok
2018
Cel
STING, A2A/A2B
Zasoby na tej stronie
Pobierz zasoby
- plik pdf
"Discovery of novel small molecule STING agonists as a new cancer immunotherapy"
Pobierz - plik pdf
“Characterization of novel dual A2A/B adenosine receptor antagonists for cancer immunotherapy”
Pobierz